Table 1.

Cohort’s demographics and GBS variants

Variables	Categories	n (%)	Male n (%)	Female n (%)
Age	50 or less	17 (56.7)	12 (70.6)	5 (29.4)
	Above 50	13 (43.3)	9 (69.2)	4 (30.8)
Seasons	Fall/Winter	16 (53.3)	11 (68.8)	5 (31.2)
	Spring/Summer	14 (46.7)	10 (71.4)	4 (28.6)
Triggers	URTI	7 (46.7)	7 (100)	0
	GIT infection	4 (26.7)	3 (75)	1 (25)
	Both URTI and GIT infection	2 (13.3)	1 (50)	1 (50)
	Covid 19	1 (6.7)	0	1 (100)
	Chickenpox	1 (6.7)	0	1 (100)
Duration between preceding infection and onset of GBS symptoms	1–7 days	6 (40)	5 (83.3)	1 (16.7)
	8–14 days	7 (46.7)	5 (71.4)	2 (28.6)
	15–21 days	1 (6.7)	1 (100)	0
	Current infection	1 (6.7)	0	1 (100)
Days from onset of symptoms to admission	1–7 days	19 (63.33)	15 (78.95)	4 (21.05)
	8–14 days	6 (20)	3 (50)	3 (50)
	>14 days	5 (16.67)	3 (60)	2 (40)
GBS variant	AIDP	18 (60)	13 (61.9)	5 (55.6)
	AMAN	5 (16.7)	3 (14.3)	2 (22.2)
	Miller-Fisher	3 (10)	2 (9.5)	1 (11.1)
	Facial Diplegia	1 (3.3)	1 (4.8)	0
	AMSAN	2 (6.7)	2 (9.5)	0
	Pure Sensory	1 (3.3)	0	1 (11.1)

GBS, Guillain–Barré syndrome; GIT, Gastrointestinal tract; URTI, Upper respiratory tract infection.